Login / Signup

Oxaliplatin-associated shock in stage III colorectal cancer patients: real-world evidence in Taiwan.

Ling-Yi WangHui-Hsia HsiehSung-Chao ChuWei-Chuan ChangYi-Ting KuoTien-Yuan Wu
Published in: Therapeutic advances in drug safety (2024)
Oxaliplatin use significantly increased shock risk in stage III CRC patients. Male sex and heart disease are two independent risk factors.
Keyphrases
  • end stage renal disease
  • risk factors
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis
  • patient reported outcomes